New blood markers to predict pregnancy diabetes and large babies
Part of Genetic & congenital, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if new blood markers can help predict gestational diabetes and the risk of having a large baby. It could lead to earlier detection and better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 years or older
- Pregnant with one baby (or twins reduced to one before 14 weeks)
- Less than 28 weeks pregnant at the time of joining
- Covered by health insurance (social security)
- Able to give consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether wearing a continuous glucose monitor (a small sensor on your skin) in early pregnancy can help predict if you will develop gestational diabetes later. The goal is to catch it early so you and your baby get the best care possible.
This trial uses artificial intelligence to help manage gestational diabetes in pregnant women. It may improve care for women diagnosed early in pregnancy.
This study is testing whether wearing a continuous glucose monitor (CGM) early in pregnancy can help find and manage high blood sugar, which may lower the risk of problems for you and your baby. You would wear a small sensor under your skin, and the device sends information to a smartphone app.
This study tests how well ultrasound can predict if a baby will be born larger than normal (macrosomia) within 24 hours of delivery. It might help parents and doctors plan for a safer birth.
This trial tests if checking for gestational diabetes later in pregnancy (after 30 weeks) in women whose baby is large can lower C-section rates. You may qualify if your baby is estimated to be large and you don't already have diabetes.
This study is looking at pregnant people who have early signs of gestational diabetes in the first half of pregnancy. It may help find safer ways to monitor or treat early diabetes-related blood sugar changes to improve pregnancy outcomes.
Hear when a new Macrosomia, Fetal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.